CoChat

Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder

Secnik, Kristina, Swensen, Andrine, Lage, Maureen J · 2005 · PharmacoEconomics

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Introduction The purpose of this retrospective study was to examine the prevalence of comorbidities, resource use, direct medical costs, and the costs associated with missed work for adults diagnosed with attention-deficit hyperactivity disorder (ADHD). Study design From a large claims database that captures inpatient, outpatient and prescription drug services, individuals diagnosed with ADHD between the years 1999 and 2001 were retrospectively identified. The ADHD cohort (n = 2252) were matched with a non-ADHD cohort (n = 2252) on a 1 : 1 ratio, based upon age, gender, metropolitan statistical area and type of insurance coverage. The ADHD cohort was compared with the non-ADHD cohort for differences in comorbidities and direct medical costs (inpatient, outpatient and prescription drug costs) using year 2001 prices. Using data from six Fortune 200 employers, time missed from work and costs associated with absenteeism, short-term disability and worker's compensation was examined for a subsample (n = 354) of the employees diagnosed with ADHD. Chi-square and t-statistics were used to compare the ADHD population with the control group with regards to comorbidites and service use. Analysis of covariance and multivariate regressions were used to examine differences in days missed from work, direct medical costs and costs associated with missed work. Results Adults diagnosed with ADHD were significantly more likely to have a comorbid diagnosis of asthma (p = 0.0014), anxiety (p Concl…

Overview

Integrity signals

Registry

Crossref · 10.2165/00019053-200523010-00008

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 37 references

Research works printed but not linked: 1

  1. Barkley, 2001, Trends in Evidence-Based Neuropsychiatry (TEN), 3, 64

Cited by

See all 247

Metadata

Authors
Secnik, K., Swensen, A., & Lage, M. J.
Affiliations
  • Eli Lilly (United States) (US)
  • Quinnipiac University (US)
Corresponding author
Lage, Maureen J
Venue
PharmacoEconomics
Published
2005
Volume
23
Issue
1
Pages
93-102
ISSN
1170-7690 (ISSN-L)
OpenAlex
W2079907329
Cited by
247
References
37
Citations by year
2026: 4 · 2025: 5 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 10 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 10 · 2016: 12 · 2015: 10 · 2014: 8 · 2013: 17 · 2012: 19
FWCI
10.22
Type
journal article
Language
en
Open access
closed
Locations
  • PharmacoEconomics (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
attention deficit hyperactivity disorder, adult ADHD, comorbidities, health care costs, resource utilization (health care), missed work, absenteeism, short-term disability, workers' compensation, asthma, depression, bipolar disorder, anxiety, substance abuse, oppositional disorder, antisocial personality disorder, economic burden, productivity loss, health care utilization, prescription drug costs, inpatient and outpatient costs
MeSH terms
Absenteeism, Adolescent, Adult, Aged, Attention Deficit Disorder with Hyperactivity, Female, Humans, Male, Middle Aged, Retrospective Studies, Workers' Compensation, Cohort Studies, Comorbidity, Case-Control Studies, Health Care Costs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder. https://app.cochat.ai/papers/10.2165/00019053-200523010-00008
The paper
Secnik, K., Swensen, A., & Lage, M. J. (2005). Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder. PharmacoEconomics. https://doi.org/10.2165/00019053-200523010-00008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.